Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,665
-$246 QoQ
Shares Held
89
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#970
of 1,033 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SWAN Capital LLC holds $786,866 across 10 Drug Manufacturers - General names. GSK ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
240 | $287,863 | |
| 2 | PFE |
Pfizer Inc
|
11,171 | $268,997 | |
| 3 | JNJ |
Johnson & Johnson
|
556 | $141,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
482 | $61,937 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
148 | $8,527 | |
| 6 | ABBV |
AbbVie Inc.
|
23 | $5,787 | |
| 7 | GSK |
GSK plc
This page
|
89 | $4,665 | |
| 8 | NVO |
Novo Nordisk A S
|
95 | $4,554 |
All Filings in GSK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,665 | 89 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,911 | 89 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,172 | 289 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,473 | 289 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,321 | 399 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,847 | 280 | Shares | Sole | 2025-05-23 | |
| 2024-12-31 | $9,469 | 280 | Shares | Sole | 2025-02-25 | |
| 2024-09-30 | $11,446 | 280 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,780 | 280 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||